학술논문
The risk of leprosy in patients using immunobiologics and conventional immunosuppressants for the treatment of dermatological and rheumatological diseases: a cohort study.
Document Type
Article
Author
Source
Subject
*LEPROSY
*IMMUNOSUPPRESSIVE agents
*COHORT analysis
*
*
Language
ISSN
0926-9959
Abstract
Dear Editor Leprosy remains prevalent in developing areas, and migration renders it an increasing concern in developed countries where the incidence of immune-mediated diseases, such as psoriasis, is high.1 We aimed to evaluate the leprosy risk in patients using immunobiologics and conventional immunosuppressants for the treatment of dermatological and rheumatological diseases. A randomized controlled trial of prednisolone vs. interleukin 17 A inhibitor secuinumab in the management of type 1 lepra reaction in leprosy patients. [Extracted from the article]